BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31489470)

  • 1. Isorhynchophylline enhances Nrf2 and inhibits MAPK pathway in cardiac hypertrophy.
    Zhang Y; Cui Y; Dai S; Deng W; Wang H; Qin W; Yang H; Liu H; Yue J; Wu D; Wang J; Guo H
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):203-212. PubMed ID: 31489470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrodin and Isorhynchophylline Synergistically Inhibit MPP
    Li Q; Niu C; Zhang X; Dong M
    ACS Chem Neurosci; 2018 Mar; 9(3):482-493. PubMed ID: 29115830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isorhynchophylline exerts anti-inflammatory and anti-oxidative activities in LPS-stimulated murine alveolar macrophages.
    Zhou Z; Su Y; Fa XE
    Life Sci; 2019 Apr; 223():137-145. PubMed ID: 30858121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cardiac hypertrophy by aromadendrin through down-regulating NFAT and MAPKs pathways.
    Cui S; Cui Y; Li Y; Zhang Y; Wang H; Qin W; Chen X; Ding S; Wu D; Guo H
    Biochem Biophys Res Commun; 2018 Dec; 506(4):805-811. PubMed ID: 30389139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis.
    Sari N; Katanasaka Y; Sugiyama Y; Sunagawa Y; Miyazaki Y; Funamoto M; Shimizu S; Shimizu K; Murakami A; Mori K; Wada H; Hasegawa K; Morimoto T
    Phytomedicine; 2021 Nov; 92():153744. PubMed ID: 34563985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice.
    Syed AM; Kundu S; Ram C; Kulhari U; Kumar A; Mugale MN; Mohapatra P; Murty US; Sahu BD
    Free Radic Biol Med; 2022 Jun; 186():17-30. PubMed ID: 35513128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
    Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
    Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
    Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF
    J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins.
    Wang W; Li S; Wang H; Li B; Shao L; Lai Y; Horvath G; Wang Q; Yamamoto M; Janicki JS; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2014 Jul; 72():305-15. PubMed ID: 24747945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
    Yuan Y; Yan L; Wu QQ; Zhou H; Jin YG; Bian ZY; Deng W; Yang Z; Shen DF; Zeng XF; Wang SS; Li H; Tang QZ
    Hypertension; 2016 Dec; 68(6):1393-1399. PubMed ID: 27698061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
    Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
    Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
    Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload.
    Guo H; Zhang X; Cui Y; Zhou H; Xu D; Shan T; Zhang F; Guo Y; Chen Y; Wu D
    Toxicol Appl Pharmacol; 2015 Sep; 287(2):168-177. PubMed ID: 26051872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis.
    Tang C; Yin G; Huang C; Wang H; Gao J; Luo J; Zhang Z; Wang J; Hong J; Chai X
    Biomed Pharmacother; 2020 Sep; 129():110357. PubMed ID: 32531679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isorhynchophylline exerts anti-asthma effects in mice by inhibiting the proliferation of airway smooth muscle cells: The involvement of miR-200a-mediated FOXC1/NF-κB pathway.
    Zhu J; Wang W; Wu X
    Biochem Biophys Res Commun; 2020 Jan; 521(4):1055-1060. PubMed ID: 31733831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
    Liu C; Wu QQ; Cai ZL; Xie SY; Duan MX; Xie QW; Yuan Y; Deng W; Tang QZ
    J Cell Mol Med; 2019 Sep; 23(9):6466-6478. PubMed ID: 31293067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin improves myocardial hypertrophy after hemodynamic pressure overload via regulating the crosstalk of Nrf2/ARE and TGF-β/ smads pathways in rat heart.
    Wang P; Luo L; Shen Q; Shi G; Mohammed A; Ni S; Wu X
    Eur J Pharmacol; 2018 Feb; 820():173-182. PubMed ID: 29225188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
    Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W
    Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.